Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Osteomacs and Bone Regeneration.

Batoon L, Millard SM, Raggatt LJ, Pettit AR.

Curr Osteoporos Rep. 2017 Aug;15(4):385-395. doi: 10.1007/s11914-017-0384-x. Review.

PMID:
28647885
2.

Role of Osteoblast Gi Signaling in Age-Related Bone Loss in Female Mice.

Millard SM, Wang L, Wattanachanya L, O'Carroll D, Fields AJ, Pang J, Kazakia G, Lotz JC, Nissenson RA.

Endocrinology. 2017 Jun 1;158(6):1715-1726. doi: 10.1210/en.2016-1365.

PMID:
28407060
3.

Gs/Gi Regulation of Bone Cell Differentiation: Review and Insights from Engineered Receptors.

Hsiao EC, Millard SM, Nissenson RA.

Horm Metab Res. 2016 Nov;48(11):689-699. Epub 2016 Sep 19. Review.

PMID:
27643449
4.

Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts.

Millard SM, Pettit AR, Ellis R, Chan JK, Raggatt LJ, Khosrotehrani K, Fisk NM.

Stem Cell Reports. 2015 Nov 10;5(5):682-9. doi: 10.1016/j.stemcr.2015.09.017. Epub 2015 Oct 29.

5.

Assessing the osteoblast transcriptome in a model of enhanced bone formation due to constitutive Gs-G protein signaling in osteoblasts.

Wattanachanya L, Wang L, Millard SM, Lu WD, O'Carroll D, Hsiao EC, Conklin BR, Nissenson RA.

Exp Cell Res. 2015 May 1;333(2):289-302. doi: 10.1016/j.yexcr.2015.02.009. Epub 2015 Feb 20.

6.

Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification.

Raggatt LJ, Wullschleger ME, Alexander KA, Wu AC, Millard SM, Kaur S, Maugham ML, Gregory LS, Steck R, Pettit AR.

Am J Pathol. 2014 Dec;184(12):3192-204. doi: 10.1016/j.ajpath.2014.08.017. Epub 2014 Oct 5.

PMID:
25285719
7.

Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription.

Abankwa D, Millard SM, Martel N, Choong CS, Yang M, Butler LM, Buchanan G, Tilley WD, Ueki N, Hayman MJ, Leong GM.

BMC Biochem. 2013 Apr 8;14:10. doi: 10.1186/1471-2091-14-10.

8.

Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?

Millard SM, Fisk NM.

Bioessays. 2013 Mar;35(3):173-82. doi: 10.1002/bies.201200087. Epub 2012 Nov 26. Review.

PMID:
23184477
9.

Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation.

Millard SM, Louie AM, Wattanachanya L, Wronski TJ, Conklin BR, Nissenson RA.

J Bone Miner Res. 2011 Apr;26(4):822-32. doi: 10.1002/jbmr.273.

10.

Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation.

Hsiao EC, Millard SM, Louie A, Huang Y, Conklin BR, Nissenson RA.

Mol Endocrinol. 2010 Mar;24(3):621-31. doi: 10.1210/me.2009-0424. Epub 2010 Feb 11.

11.

The Ski proto-oncogene regulates body composition and suppresses lipogenesis.

Leong GM, Kee AJ, Millard SM, Martel N, Eriksson N, Turner N, Cooney GJ, Hardeman EC, Muscat GE.

Int J Obes (Lond). 2010 Mar;34(3):524-36. doi: 10.1038/ijo.2009.265. Epub 2009 Dec 22.

PMID:
20029376
12.

The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X.

Mouchantaf R, Azakir BA, McPherson PS, Millard SM, Wood SA, Angers A.

J Biol Chem. 2006 Dec 15;281(50):38738-47. Epub 2006 Oct 12.

13.

Riding the DUBway: regulation of protein trafficking by deubiquitylating enzymes.

Millard SM, Wood SA.

J Cell Biol. 2006 May 22;173(4):463-8. Epub 2006 May 15. Review.

14.

The acute effects of amiloride and potassium canrenoate on digoxin-induced positive inotropism in healthy volunteers.

Richter JP, Sommers DK, Snyman JR, Millard SM.

Eur J Clin Pharmacol. 1993;45(2):195-6. No abstract available.

PMID:
8223845
15.

Maintaining control of the Alzheimer's unit.

Millard SM.

Nurs Homes Sr Citiz Care. 1989 Oct;38(1-2):13-6. No abstract available.

PMID:
10318340

Supplemental Content

Loading ...
Support Center